A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
type: MedicalStudy
description: A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2010-03
end date: 2014-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00946699
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: MedImmune LLC
study subject: Scleroderma
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Scleroderma

AI Analytics
type: Organization